Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens

Ethan Rubinstein*, Tahaniyat Lalani, G. Ralph Corey, Zeina A. Kanafani, Esteban C. Nannini, Marcelo G. Rocha, Galia Rahav, Michael S. Niederman, Marin H. Kollef, Andrew F. Shorr, Patrick C. Lee, Arnold L. Lentnek, Carlos M. Luna, Jean Yves Fagon, Antoni Torres, Michael M. Kitt, Fredric C. Genter, Steven L. Barriere, H. David Friedland, Martin E. Stryjewski

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

228 Scopus citations

Fingerprint

Dive into the research topics of 'Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens'. Together they form a unique fingerprint.

Medicine & Life Sciences